TabMenu

Poverty and InequalitySexual and Reproductive HealthFamily, Maternal & Child HealthMethodology

Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial

TitleCircumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial
Publication TypeJournal Article
Year of Publication2009
AuthorsWawer, MJ, Makumbi, F, Kigozi, G, Serwadda, D, Watya, S, Nalugoda, F, Buwembo, D, Ssempijja, V, Kiwanuka, N, Moulton, LH, Sewankambo, NK, Reynolds, SJ, Quinn, TC, Opendi, P, Iga, B, Ridzon, R, Laeyendecker, O, Gray, RH
JournalLancet
Volume374
Pagination229-237
Date PublishedJul 18
ISBN Number1474-547X; 0140-6736
Accession Number19616720
KeywordsAdolescent, Adult, Attitude to Health/ethnology, Circumcision, Male/adverse effects/ethnology, Female, Follow-Up Studies, Health Knowledge, Attitudes, Practice, HIV Infections/ethnology/prevention & control/transmission, Humans, Kaplan-Meiers Estimate, Male, Middle Aged, Patient Education as Topic, Proportional Hazards Models, Risk Reduction Behavior, Sex Education, Sexual Partners/psychology, Stereotyping, Survival Analysis, Time Factors, Uganda/epidemiology, Women's Health/ethnology, Wound Healing, Young Adult
Abstract

BACKGROUND: Observational studies have reported an association between male circumcision and reduced risk of HIV infection in female partners. We assessed whether circumcision in HIV-infected men would reduce transmission of the virus to female sexual partners. METHODS: 922 uncircumcised, HIV-infected, asymptomatic men aged 15-49 years with CD4-cell counts 350 cells per microL or more were enrolled in this unblinded, randomised controlled trial in Rakai District, Uganda. Men were randomly assigned by computer-generated randomisation sequence to receive immediate circumcision (intervention; n=474) or circumcision delayed for 24 months (control; n=448). HIV-uninfected female partners of the randomised men were concurrently enrolled (intervention, n=93; control, n=70) and followed up at 6, 12, and 24 months, to assess HIV acquisition by male treatment assignment (primary outcome). A modified intention-to-treat (ITT) analysis, which included all concurrently enrolled couples in which the female partner had at least one follow-up visit over 24 months, assessed female HIV acquisition by use of survival analysis and Cox proportional hazards modelling. This trial is registered with ClinicalTrials.gov, number NCT00124878. FINDINGS: The trial was stopped early because of futility. 92 couples in the intervention group and 67 couples in the control group were included in the modified ITT analysis. 17 (18%) women in the intervention group and eight (12%) women in the control group acquired HIV during follow-up (p=0.36). Cumulative probabilities of female HIV infection at 24 months were 21.7% (95% CI 12.7-33.4) in the intervention group and 13.4% (6.7-25.8) in the control group (adjusted hazard ratio 1.49, 95% CI 0.62-3.57; p=0.368). INTERPRETATION: Circumcision of HIV-infected men did not reduce HIV transmission to female partners over 24 months; longer-term effects could not be assessed. Condom use after male circumcision is essential for HIV prevention. FUNDING: Bill & Melinda Gates Foundation with additional laboratory and training support from the National Institutes of Health and the Fogarty International Center.

PMCID

2905212